| # | Title | Journal | Year | Citations |
|---|
| 1 | Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce — Part 1: definition and development of a standardised, consensus-based scoring system | RMD Open | 2017 | 250 |
| 2 | Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis | RMD Open | 2015 | 235 |
| 3 | EULAR Sjogren's syndrome disease activity index (ESSDAI): a user guide | RMD Open | 2015 | 229 |
| 4 | Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations | RMD Open | 2018 | 227 |
| 5 | Glucocorticoid-induced osteoporosis | RMD Open | 2015 | 223 |
| 6 | Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial | RMD Open | 2021 | 183 |
| 7 | Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity | RMD Open | 2017 | 161 |
| 8 | Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group | RMD Open | 2018 | 155 |
| 9 | Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 2: reliability and application to multiple joints of a standardised consensus-based scoring system | RMD Open | 2017 | 149 |
| 10 | Post-traumatic arthritis: overview on pathogenic mechanisms and role of inflammation | RMD Open | 2016 | 145 |
| 11 | Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview | RMD Open | 2016 | 142 |
| 12 | Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt– a national health survey | RMD Open | 2016 | 133 |
| 13 | Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey | RMD Open | 2021 | 121 |
| 14 | Reactive arthritis after COVID-19 infection | RMD Open | 2020 | 117 |
| 15 | EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report | RMD Open | 2017 | 115 |
| 16 | Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations | RMD Open | 2019 | 113 |
| 17 | Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD | RMD Open | 2019 | 104 |
| 18 | Pathophysiology of osteoarthritis: canonical NF-κB/IKKβ-dependent and kinase-independent effects of IKKα in cartilage degradation and chondrocyte differentiation | RMD Open | 2015 | 103 |
| 19 | Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease | RMD Open | 2015 | 103 |
| 20 | Synovial tissue macrophages: friend or foe? | RMD Open | 2017 | 103 |
| 21 | Early knee osteoarthritis: Figure 1 | RMD Open | 2015 | 100 |
| 22 | Synovial fibroblasts in 2017 | RMD Open | 2017 | 100 |
| 23 | Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme | RMD Open | 2020 | 100 |
| 24 | Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis | RMD Open | 2017 | 99 |
| 25 | Rheumatoid arthritis treatment: the earlier the better to prevent joint damage | RMD Open | 2015 | 98 |
| 26 | Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives | RMD Open | 2019 | 97 |
| 27 | Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study | RMD Open | 2019 | 92 |
| 28 | Systemic sclerosis: state of the art on clinical practice guidelines | RMD Open | 2019 | 91 |
| 29 | Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis | RMD Open | 2015 | 90 |
| 30 | Effects of exercise and physical activity promotion: meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip/knee osteoarthritis | RMD Open | 2018 | 90 |
| 31 | Distinguishing rheumatoid arthritis from psoriatic arthritis | RMD Open | 2018 | 90 |
| 32 | Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies | RMD Open | 2016 | 89 |
| 33 | Glucocorticoids in rheumatoid arthritis: current status and future studies | RMD Open | 2020 | 89 |
| 34 | Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort | RMD Open | 2016 | 88 |
| 35 | Salivary gland ultrasound abnormalities in primary Sjögren’s syndrome: consensual US-SG core items definition and reliability | RMD Open | 2017 | 87 |
| 36 | Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis | RMD Open | 2015 | 86 |
| 37 | Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis | RMD Open | 2015 | 85 |
| 38 | Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next | RMD Open | 2017 | 84 |
| 39 | Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?: Table 1 | RMD Open | 2015 | 83 |
| 40 | Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases | RMD Open | 2021 | 82 |
| 41 | Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behçet's disease | RMD Open | 2016 | 81 |
| 42 | Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies | RMD Open | 2015 | 80 |
| 43 | Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines | RMD Open | 2016 | 77 |
| 44 | Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis | RMD Open | 2019 | 77 |
| 45 | Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice | RMD Open | 2017 | 76 |
| 46 | What makes psoriatic and rheumatoid arthritis so different? | RMD Open | 2015 | 75 |
| 47 | Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review | RMD Open | 2021 | 75 |
| 48 | Digital rheumatology in the era of COVID-19: results of a national patient and physician survey | RMD Open | 2021 | 74 |
| 49 | EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases | RMD Open | 2019 | 73 |
| 50 | Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey | RMD Open | 2021 | 72 |
